Dies ist eine HTML Version eines Anhanges der Informationsfreiheitsanfrage 'The Vaccines Procurement Steering Committee & the Joint Negotiation Team'.




 
 
 
  
 
: 
(a) 
 
 

 
 
In order for the EU (COM and Members States) contribution to be as meaningful as possible: 
x  the EU will contribute to the upfront payment ; 
x  since the participation of countries in the Governing body is for self-financing countries, 
the EU contribution will automatically allow all EU MS  participate in the COVAX 
shareholders Council;  
x  the doses will be transferred to developing countries,  ; 
x  participation for all MSs in the self-financing part 
 
It was also outlined that any additional contribution of MSs would be more useful in the 
Advance Market Commitment pillar (AMC), considering that the upfront payment in the self-
financing pillar is already covered with the  EU contribution. 
Regarding the questions raised by the MSs 
 the 
 clarified 
that: 
x  the ongoing process did NOT exclude MSs, but it was a collective effort by the COM 
and MSs within the Team Europe

x  the ongoing process was NOT excluding or discriminating  any vaccine – which can be 
available to the EU market provided that they are assessed by EMA and go through the 
EU authorization process;  
x  we are committed to universality of vaccines- one example being the almost 2,7 billion 
upfront payment the EU was investing that secures not only the interest of the EU 
citizens but also production capacity for the whole world; 
Commission confirmed that a Press statement would be published on the deadline the 18 
September.